Top Stories

China vaccine maker Sinopharm says chairman and a director resigned


A health worker shows a dose of China’s Sinopharm Covid-19 vaccine at a vaccination center in the Jordanian capital Amman on January 13, 2021.

Khalil Mazraawi | AFP | Getty Images

BEIJING — Sinopharm, a state-owned giant in China’s coronavirus vaccine development, announced its chairman left the board Tuesday.

The company cited personal reasons for Li Zhiming’s resignation, according to a filing for the Hong Kong-listed company. Li Hui, a director and audit committee member of Sinopharm subsidiary China National Medicines Corp. also resigned Tuesday due to personal reasons, a separate filing disclosed.

In late December, Chinese authorities approved a vaccine developed by a Beijing-based…


Powell sees no interest rate hikes on the horizon as long as inflation stays low

Previous article

This company threatened to ax workers refusing the vaccine, by threatening a ‘no jab, no job policy’

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories